Nicholas Lillo
Obstetrics & Gynecology · New Britain, CTNPI 1871573683
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,111 and has fallen 91.7% since, to $92 in 2025.
Across 158 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$497
- AbbVie$432
- Astellas Pharma US Inc$400
- Takeda Pharmaceuticals U.S.A., Inc.$194
- Lupin Inc.$179
- Exeltis, USA Inc.$176
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,75795%
- Education$1435%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $497 |
| AbbVie(2 entities) | 23 | $432 |
| Astellas Pharma US Inc | 20 | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $194 |
| Lupin Inc. | 12 | $179 |
| Exeltis, USA Inc. | 8 | $176 |
| Mylan Pharmaceuticals Inc. | 11 | $167 |
| AMAG Pharmaceuticals, Inc. | 8 | $143 |
| Gilead | 8 | $124 |
| Avion Pharmaceuticals | 6 | $77 |
| Coopersurgical, Inc. | 5 | $72 |
| Merck | 4 | $63 |
| Ardelyx, Inc. | 3 | $53 |
| Duchesnay USA Incorporated | 2 | $49 |
| Ferring Pharmaceuticals Inc. | 3 | $47 |
| Aspira Women's Health Inc | 1 | $43 |
| Braintree Laboratories, Inc. | 2 | $29 |
| Avanos Medical | 1 | $25 |
| Boehringer Ingelheim | 1 | $20 |
| Roche Diagnostics Corporation | 1 | $19 |
| Bayer | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $14 |
| Acelrx Pharmaceuticals, Inc. | 1 | $12 |
| Hologic Sales And Service, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRULANCE$125
How this compares
$2,900 in reported general payments places this provider in the 85th percentile of 605 obstetrics & gynecology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 12 | $123 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New Britain
- Kyle BakerNew Britain$7K
- Gerard RoyNew Britain$6K
- Stephanie GarozzoNew Britain$5K
- Lisa RinaldiNew Britain$5K
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.